About the HPTN

Image of site monitoring staff at work.

The HPTN is dedicated to the discovery and development of new and innovative research strategies to reduce the acquisition and transmission of HIV.

 

Established in 2000, the HIV Prevention Trials Network (HPTN) is a worldwide collaborative clinical trials network that brings together investigators, ethicists, community and other partners to develop and test the safety and efficacy of interventions designed to prevent the acquisition and transmission of HIV. HPTN studies and evaluates new HIV prevention interventions and strategies in populations and geographical regions that bear a disproportionate burden of infection. The HPTN is committed to the highest ethical standards for its clinical trials and recognizes the importance of community engagement in all phases of the research process.

 

HPTN Research Agenda

The HPTN research agenda focuses on integrated strategies toward:
 

  • Antiretroviral Drug Use

    Including antiretroviral therapy and pre-exposure prophylaxis
     
     

  • Interventions for Substance Abuse

    Particularly injection drug use
     
     

  • Behavioral Risk Reduction Interventions

    Including structural interventions

Learn More